American Century Companies’s NewAmsterdam Pharma NAMS Stock Holding History

American Century Companies's NAMS Position: Q2 2026 in Review

American Century Companies increased its NewAmsterdam Pharma (NAMS) stake by 32% in Q2 2026, buying an estimated $5.45M and bringing the position to 684,813 shares worth $23.2M. The position accounts for 0.01% of the portfolio, ranked #1228.

American Century Companies first reported a position in NAMS in Q4 2024 and has held it in 7 quarters since. 178 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

• American Century Companies held 684,813 shares of NewAmsterdam Pharma worth $23.2M as of Q2 2026.
• American Century Companies bought 165,358 NewAmsterdam Pharma shares in Q2 2026, an estimated $5.45M.
• NewAmsterdam Pharma made up 0.01% of American Century Companies's portfolio in Q2 2026, its #1228 holding.
• American Century Companies first reported a position in NewAmsterdam Pharma in Q4 2024 and has held it in 7 quarters since.
• 178 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.